These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 31140551)

  • 1. Activation of the NF-κB Pathway and Heterozygous Deletion of TNFAIP3 (A20) Confer Superior Survival in Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type.
    Liu F; Zheng JP; Wang L; Zhao DH; Li MY; Wang YM; Liu Y; Ma J; Zeng NY; Liu HX; Liang R; Guo SP; Wang Z; Yan QG
    Am J Clin Pathol; 2019 Jul; 152(2):243-252. PubMed ID: 31140551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic implications of TNFAIP3/A20 deletions in extranodal NK/T-cell lymphoma.
    Ahn H; Yang JM; Jeon YK; Paik JH
    Genes Chromosomes Cancer; 2018 May; 57(5):231-239. PubMed ID: 29380463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NF-kappaB activation through the alternative pathway correlates with chemoresistance and poor survival in extranodal NK/T-cell lymphoma, nasal type.
    Liu X; Wang B; Ma X; Guo Y
    Jpn J Clin Oncol; 2009 Jul; 39(7):418-24. PubMed ID: 19395464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem cell deficiency influences megakaryocytopoiesis through the TNFAIP3/NF-κB/SMAD pathway in patients with immune thrombocytopenia.
    He Y; Xu LL; Feng FE; Wang QM; Zhu XL; Wang CC; Zhang JM; Fu HX; Xu LP; Liu KY; Huang XJ; Zhang XH
    Br J Haematol; 2018 Feb; 180(3):395-411. PubMed ID: 29327472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A20 (TNFAIP3) Alterations in Primary Intestinal Diffuse Large B-cell Lymphoma.
    Fujii M; Takata K; Chuang SS; Miyata-Takata T; Ando M; Sato Y; Yoshino T
    Acta Med Okayama; 2018 Feb; 72(1):23-30. PubMed ID: 29463935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel missense mutation in TNFAIP3 causes haploinsufficiency of A20.
    Jiang W; Deng M; Gan C; Wang L; Mao H; Li Q
    Cell Immunol; 2022 Jan; 371():104453. PubMed ID: 34808442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation analysis of tumor necrosis factor alpha-induced protein 3 gene in Hodgkin lymphoma.
    Etzel BM; Gerth M; Chen Y; Wünsche E; Facklam T; Beck JF; Guntinas-Lichius O; Petersen I
    Pathol Res Pract; 2017 Mar; 213(3):256-260. PubMed ID: 28189285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated oncogenic pathways and therapeutic targets in extranodal nasal-type NK/T cell lymphoma revealed by gene expression profiling.
    Ng SB; Selvarajan V; Huang G; Zhou J; Feldman AL; Law M; Kwong YL; Shimizu N; Kagami Y; Aozasa K; Salto-Tellez M; Chng WJ
    J Pathol; 2011 Mar; 223(4):496-510. PubMed ID: 21294123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations of CARD11 but not TNFAIP3 may activate the NF-kappaB pathway in primary CNS lymphoma.
    Montesinos-Rongen M; Schmitz R; Brunn A; Gesk S; Richter J; Hong K; Wiestler OD; Siebert R; Küppers R; Deckert M
    Acta Neuropathol; 2010 Oct; 120(4):529-35. PubMed ID: 20544211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic activation of NF-κB by TNFAIP3 (A20) reduction and UBE2L3 (UBCH7) augment that synergistically elevate lupus risk.
    Kim T; Bae SC; Kang C
    Arthritis Res Ther; 2020 Apr; 22(1):93. PubMed ID: 32334614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mutational landscape of ocular marginal zone lymphoma identifies frequent alterations in TNFAIP3 followed by mutations in TBL1XR1 and CREBBP.
    Jung H; Yoo HY; Lee SH; Shin S; Kim SC; Lee S; Joung JG; Nam JY; Ryu D; Yun JW; Choi JK; Ghosh A; Kim KK; Kim SJ; Kim WS; Park WY; Ko YH
    Oncotarget; 2017 Mar; 8(10):17038-17049. PubMed ID: 28152507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aggressive natural killer (NK)-cell leukaemia and extranodal NK/T-cell lymphoma are two distinct diseases that differ in their clinical presentation and cytogenetic findings.
    Yang CF; Hsu CY; Ho DM
    Histopathology; 2018 May; 72(6):955-964. PubMed ID: 29314186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [CD16 expression is an independent prognostic factor for extranodal NK/T cell lymphoma of nasal type].
    Zuo Z; Yang QP; Tang Y; Zhao S; Yu JB; Liu YM; Gao LM; Liu WP
    Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):227-33. PubMed ID: 23928528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High throughput sequencing reveals high specificity of TNFAIP3 mutations in ocular adnexal marginal zone B-cell lymphomas.
    Vela V; Juskevicius D; Gerlach MM; Meyer P; Graber A; Cathomas G; Dirnhofer S; Tzankov A
    Hematol Oncol; 2020 Aug; 38(3):284-292. PubMed ID: 32012328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A20/Tumor Necrosis Factor α-Induced Protein 3 in Immune Cells Controls Development of Autoinflammation and Autoimmunity: Lessons from Mouse Models.
    Das T; Chen Z; Hendriks RW; Kool M
    Front Immunol; 2018; 9():104. PubMed ID: 29515565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant Expression of Prohibitin Is Related to Prognosis of Nasal Extranodal Natural Killer/T Cell Lymphoma, Nasal Type.
    Guo WW; Chen LH; Yin W; Mo LX
    Oncol Res Treat; 2020; 43(10):491-497. PubMed ID: 32756049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNGR1-mediated deletion of A20/Tnfaip3 in dendritic cells alters T and B-cell homeostasis and promotes autoimmune liver pathology.
    Das T; Bergen IM; Koudstaal T; van Hulst JAC; van Loo G; Boonstra A; Vanwolleghem T; Leung PSC; Gershwin ME; Hendriks RW; Kool M
    J Autoimmun; 2019 Aug; 102():167-178. PubMed ID: 31151831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-2 induces NF-kappaB activation through BCL10 and affects its subcellular localization in natural killer lymphoma cells.
    Chan KK; Shen L; Au WY; Yuen HF; Wong KY; Guo T; Wong ML; Shimizu N; Tsuchiyama J; Kwong YL; Liang RH; Srivastava G
    J Pathol; 2010 Jun; 221(2):164-74. PubMed ID: 20235165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TNFAIP3 overexpression is an independent factor for poor survival in esophageal squamous cell carcinoma.
    Hadisaputri YE; Miyazaki T; Yokobori T; Sohda M; Sakai M; Ozawa D; Hara K; Honjo H; Kumakura Y; Kuwano H
    Int J Oncol; 2017 Mar; 50(3):1002-1010. PubMed ID: 28197630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma.
    Schmitz R; Hansmann ML; Bohle V; Martin-Subero JI; Hartmann S; Mechtersheimer G; Klapper W; Vater I; Giefing M; Gesk S; Stanelle J; Siebert R; Küppers R
    J Exp Med; 2009 May; 206(5):981-9. PubMed ID: 19380639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.